Dr. Ruby Havistin, MD

Dr. Havistin practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. Havistin's NPI, 1477999159, was assigned on May 21, 2013. Dr. Havistin holds West Virginia license 32126.

Dr. Havistin's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. Havistin's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. Havistin is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Dr. Havistin to 4 more hospitals and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Havistin practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Havistin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Havistin is licensed in West Virginia.

CMS data shows 102 Medicare services from Dr. Havistin across 4 procedure codes in 2024, for 157 Medicare patients. Medicare paid $5,948 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 157 Medicare patients who saw Dr. Havistin in 2024. The largest group is 75 to 84, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Havistin's median patient age at 71, with 42% women.

In 2024, Dr. Havistin wrote 83 Medicare Part D claims for 19 patients. 92% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $157 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Havistin for performance year 2024, reported through an alternative payment model (APM). Dr. Havistin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Havistin, published from 2022 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Predictive Value of Tests, Coronary Angiography and Coronary Artery Disease. Dr. Havistin has published most often in Coron Artery Dis. Dr. Havistin's most frequent co-authors are Matthew J. Budoff, MD, Suvasini Lakshmanan, MD and Sardar Alamzaib, MD.

CMS Open Payments shows 96 general payments to Dr. Havistin from 13 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 47% of the total. HeartFlow, Inc. paid the most, $1,699.